Molecular therapy of the intervertebral disc

Eur Spine J. 2006 Aug;15 Suppl 3(Suppl 3):S379-88. doi: 10.1007/s00586-006-0155-3. Epub 2006 Jul 12.

Abstract

Disc degeneration is the loss of the normal nucleus pulposus disc matrix to a more fibrotic and less cartilaginous structure. This change in disc micro-anatomy can be associated with pain and deformity, however, prevention and treatment options of disc degeneration are currently limited. Much research is going on to understand intervertebral discs at a molecular/ cellular level in hopes of creating clinically applicable options for treating disc degeneration. This review article will give insight into the current and developing status of treating intervertebral disc degeneration from a molecular standpoint.

Publication types

  • Review

MeSH terms

  • Collagen / chemistry
  • Collagen / metabolism
  • Extracellular Matrix / chemistry
  • Extracellular Matrix / metabolism
  • Fibrocartilage / chemistry
  • Fibrocartilage / metabolism
  • Fibrocartilage / physiopathology
  • Humans
  • Intercellular Signaling Peptides and Proteins / metabolism
  • Intervertebral Disc / chemistry*
  • Intervertebral Disc / metabolism*
  • Intervertebral Disc / physiopathology
  • Intervertebral Disc Displacement / metabolism*
  • Intervertebral Disc Displacement / physiopathology
  • Intervertebral Disc Displacement / therapy*
  • Proteoglycans / metabolism
  • Regeneration / physiology
  • Signal Transduction / physiology

Substances

  • Intercellular Signaling Peptides and Proteins
  • Proteoglycans
  • Collagen